TACR3 and neoplasm: Future research should explore areas related to how the tumor bone microenvironment regulates the stem cells; the interaction of NK-3R with other neuropeptides, cytokines, and hormones; and the potential role of NK-3R antagonists as effective therapeutic agents [39,63].